UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act Of 1934
Date of Report (Date of earliest event reported): May 9,
2022
ATI PHYSICAL THERAPY, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-39439
|
85-1408039
|
|
(State or other
jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
790 Remington Boulevard
Bolingbrook, Illinois
|
60440
|
|
(Address of
principal executive offices)
|
(Zip
Code)
|
(630) 296-2223
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the
Act:
|
Title of Each Class
|
|
Trading
Symbol
|
|
Name of Each Exchange
on Which Registered
|
|
Class A Common
Stock, $0.0001 par value
|
|
ATIP
|
|
New York Stock
Exchange
|
|
Redeemable Warrants, each whole warrant exercisable for one share
of Class A Common Stock at an exercise price of $11.50 per
share
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§
230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
|
Item 2.02 |
Results of Operation and Financial
Condition.
|
On May 9, 2022, ATI Physical Therapy, Inc. (the “Company”) issued a
press release (the “Press Release”) announcing financial results
for the first quarter of 2022 and reaffirming guidance for full
year 2022. A copy of the Press Release is furnished as Exhibit 99.1
to this report and is incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the
information under Item 2.02 and Exhibit 99.1 is being furnished and
shall not be deemed “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”),
or otherwise subject to the liabilities of that section, nor shall
such information be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act,
except as shall be expressly set forth by specific reference in
such filing.
|
Item 9.01 |
Financial Statements and
Exhibits.
|
EXHIBIT INDEX
|
Exhibit
Number
|
|
Description
|
|
|
|
Press Release
issued by ATI Physical Therapy, Inc. on May 9, 2022.
|
|
104
|
|
Cover Page Interactive Data File
(embedded within the Inline XBRL document)
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly
authorized.
|
Dated: May 9, 2022
|
ATI Physical
Therapy, Inc.
|
|
|
|
|
|
|
By:
|
/s/ Joseph
Jordan
|
|
|
Name:
|
Joseph
Jordan
|
|
|
Title:
|
Chief Financial Officer
|
